Fibrogen Inc financial data

Symbol
FGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Bay Street, Suite 100 #6009, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 139 % -20.9%
Quick Ratio 11.9 % -26.2%
Debt-to-equity -204 % +54.6%
Return On Equity 22.5 % -91.5%
Return On Assets -16.7 % +71.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +1.45%
Common Stock, Shares, Outstanding 101M shares +2.17%
Entity Public Float 88.4M USD -66.2%
Common Stock, Value, Issued 1.01M USD +2.13%
Weighted Average Number of Shares Outstanding, Basic 100M shares +2.82%
Weighted Average Number of Shares Outstanding, Diluted 100M shares +2.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 29.6M USD -36.7%
Cost of Revenue 15.6M USD +293%
Research and Development Expense 95.7M USD -64.1%
Costs and Expenses 180M USD -51.3%
Operating Income (Loss) -150M USD +53.4%
Nonoperating Income (Expense) 5.3M USD -30.3%
Income Tax Expense (Benefit) -269K USD -6.75%
Net Income (Loss) Attributable to Parent -47.6M USD +83.3%
Earnings Per Share, Basic -0.48 USD/shares +83.6%
Earnings Per Share, Diluted -0.48 USD/shares +83.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50.5M USD -38.1%
Accounts Receivable, after Allowance for Credit Loss, Current 481K USD -90.6%
Inventory, Net 3.16M USD -81.6%
Other Assets, Current 1.14M USD -83%
Assets, Current 197M USD -40.7%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1.41M USD -44.6%
Assets 215M USD -49.3%
Accounts Payable, Current 5.06M USD -67.9%
Employee-related Liabilities, Current 4.64M USD -71%
Accrued Liabilities, Current 62M USD -53.4%
Contract with Customer, Liability, Current 27.3M USD +114%
Liabilities, Current 133M USD -38.8%
Contract with Customer, Liability, Noncurrent 115M USD -27.2%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 822K USD -71.2%
Liabilities 398M USD -32%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.73M USD +16.6%
Retained Earnings (Accumulated Deficit) -1.89B USD -2.58%
Stockholders' Equity Attributable to Parent -226M USD -10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -205M USD -11.7%
Liabilities and Equity 215M USD -49.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -59.3M USD +41.6%
Net Cash Provided by (Used in) Financing Activities -165K USD -101%
Net Cash Provided by (Used in) Investing Activities 51.3M USD -50.4%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 101M shares +2.17%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.95M USD -124%
Deferred Tax Assets, Valuation Allowance 453M USD +6.19%
Deferred Tax Assets, Gross 453M USD +3.83%
Operating Lease, Liability 2M USD -97.6%
Depreciation 810K USD -68.1%
Payments to Acquire Property, Plant, and Equipment 29K USD -95.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.4M USD +83.7%
Lessee, Operating Lease, Liability, to be Paid 90.3M USD -12.7%
Property, Plant and Equipment, Gross 0 USD -100%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.8M USD +8.87%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.6M USD +26.2%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -105%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.74M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.1M USD -1.98%
Deferred Tax Assets, Operating Loss Carryforwards 206M USD +17.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 125M shares 0%
Unrecognized Tax Benefits 74.3M USD -8.27%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.5M USD +2.64%
Additional Paid in Capital 1.67B USD +1.52%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 20K USD -99.8%
Interest Expense 8.25M USD +1.88%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%